Interstitial glucose levels were monitored using the CGM System (iPro2®, Medtronic, Northridge, CA), which records glucose level every 5 min for up to 72 h. Sensor calibration was accomplished by self-monitored blood glucose values measured by OneTouch UltraVue (Johnson & Johnson, Tokyo, Japan). The mean blood glucose level, standard deviation (SD), mean amplitude of glycemic excursion (MAGE), percentage of time at blood glucose <70.2 mg/dl, and percentage of time at blood glucose ≥180 mg/dl were measured from the data recorded through CGM.
Onetouch ultravue
Manufactured by Johnson & Johnson
Sourced in United States, Japan
The OneTouch UltraVue is a blood glucose monitoring system designed to measure and display blood glucose levels. It provides accurate and reliable results to help individuals manage their diabetes.
Automatically generated - may contain errors
Lab products found in correlation
Ipro2, by Medtronic (2 mentions)
Cgms gold, by Medtronic (1 mentions)
Glucose assay kit wst, by Dojindo Laboratories (1 mentions)
Antsense 3, by Horiba (1 mentions)
Lbis mouse albumin elisa kit, by Fujifilm (1 mentions)
Streptozotocin (stz), by Fujifilm (1 mentions)
Streptozotocin (stz), by Johnson & Johnson (1 mentions)
Bio plex, by Bio-Rad (1 mentions)
Rat insulin enzyme linked immunosorbent assay elisa kit, by Thermo Fisher Scientific (1 mentions)
Streptozotocin (stz), by Merck Group (1 mentions)
14 protocols using onetouch ultravue
1
Continuous Glucose Monitoring and Glycemic Metrics
2
Glucose Tolerance Test Protocol
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
After fasting for 15 hours, a glucose solution was intraperitoneally injected (1 g/kg body weight). Blood was obtained from the tail vein before (0 minutes) and at 15, 30, 60, and 120 minutes after the injection. Glucose levels were measured by a ONETOUCH UltraVue (Johnson & Johnson, Tokyo, Japan).
3
Circadian Monitoring of Glycemia
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Blood samples in each group were obtained from the caudal vein at the same time of day (10:00 am-11:00 am) once a week for 17 weeks of treatment in rats and once a week for 4 consecutive weeks of treatment in mice. Blood glucose was measured by using a blood glucose meter, ONETOUCH Ultra Vue (Johnson & Johnson Corp., New Brunswick, NJ, USA).
4
Continuous Glucose Monitoring and Glycemic Metrics
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Blood glucose levels were measured for two consecutive days by CGM (CGMS-gold; Medtronic Minimed, Northridge, CA, USA) with SMBG using portable blood glucose meters (One Touch UltraVue; Johnson & Johnson, Tokyo, Japan). We evaluated the 8-hour glucose AUC using MIET and CGM. Moreover, we evaluated several CGM-related parameters [9 ]. Mean glucose levels, standard deviations (SDs) and coefficient of variation (CV) were calculated for all glucose data for 8 hours [9 ]. The mean amplitude of glucose excursion (MAGE) was calculated as the arithmetic mean of the differences between consecutive blood glucose peaks and nadirs provided that the differences are greater than one SD of the mean glucose value. M value was calculated with following formula: ∑ |10×log (blood glucose/100)|3/n, and the J index was calculated as follows: 0.001 (mean blood glucose+SD)2 [15 (link)16 (link)17 (link)].
5
Glucose Tolerance Evaluation Protocol
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
After overnight fasting for 16 h, FG levels were measured with glucometer (Onetouch UltraVue, Johnson & Johnson, USA) through the tail vein. IPGTT was performed by intraperitoneal injection of 2 g/kg glucose. Then blood glucose levels at 15, 30, 60, 90, and 120 min following glucose injection were measured via the tail vein.
6
Continuous Glucose Monitoring During TPN
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
The One Touch Ultra Vue glucometer (Johnson and Johnson, USA) was used to collect BG levels 6 times per day (interval survey 6 h during each time) during the whole TPN infusion. The average BG values within 24 h were considered BG levels for a giving day.
7
Urinary Biomarkers for Glucose Homeostasis
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
The level of blood glucose was determined using tail blood and a OneTouch UltraVue (Johnson & Johnson) or Antsense III (Horiba) glucometer. Urinary albumin was measured in the 24-h urine collections using an LBIS Mouse Albumin ELISA Kit according to the manufacturer's instructions (Fujifilm). The urine creatinine concentration of the 24-h urine was detected by using the LC‒MS/MS method, and urine osmolality was examined by a freezing point depression method. For assessment of fractional excretion of glucose, the urine glucose concentration was measured by using a Glucose Assay Kit-WST according to the manufacturer's instructions (Dojindo).
8
Diabetes Induction in Mice
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
STZ (WAKO, Tokyo, Japan) was injected into 6-week-old male mice for five days (50 mg/kg/day via intraperitoneal injection). Blood glucose was measured by OneTouch® UltraVue (Johnson and Johnson, New Brunswick, NJ, USA) three days after the STZ injection, and was defined as true diabetes, not prediabetes, if the serum glucose levels were higher than 250 mg/dl.
9
Oral Glucose Tolerance Test in Mice
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Mice were fasted for 6 h before the OGTT. Fasting glucose levels were measured using a OneTouch UltraVue glucometer (Johnson & Johnson, New Brunswick, NJ, USA) and LFS Quick Sensor (Johnson & Johnson). The fasted mice were orally gavaged with a 20% (w/v) glucose solution (2 g/kg body weight (BW)). Thereafter, blood glucose levels were measured at 15, 30, 60, and 120 min.
10
Continuous Glucose Monitoring in Acute Coronary Syndrome
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
All patients underwent continuous glucose monitoring (CGM) for 48 h during the subacute period (7–10 days after emergent PCI and admission) using a CGMS (iPro2; Medtronic, Minneapolis, Minnesota, USA). The CGMS sensor was inserted under the skin to measure glucose levels in tissue fluid. We calibrated the CGMS with finger sticks four times per day (Onetouch Ultravue; Johnson & Johnson, New Brunswick, New Jersey, USA) to ensure optimal accuracy of the glucose sensor. Energy-controlled meals were served (25–28 kcal/kg of ideal body weight). The recorded 48-h CGM data were independently analyzed by two cardiologists who were blinded to the MBG and STRes data of each patient (Fig. 1 ). The SD, mean, minimum, and maximum PG during CGM were recorded. Time in hypoglycemia was defined as the time when PG levels were less than 70 mg/dl. The MAGE was calculated as the average value of the blood glucose fluctuation range that exceeded 1 SD of the mean glucose 15 (link).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!